Microcapsule type tylosin tartrate preparation and production technology thereof

A technology for the production of tylvalosin and its production process, which is applied in the field of microcapsule tyvanectin tartrate preparations and its production process. The method is simple and easy, the production cost is low, and the production efficiency is high

Pending Publication Date: 2017-12-01
内蒙古中牧生物药业有限公司
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In order to solve the technical problems that the existing tylosin tartrate preparation method is complicated, the production efficiency is low, the anti-oxidation performance of the produced preparation is not good, the degradation speed of the finished product is fast, and the quality is difficult to control, the present invention provides a simple preparation method and low production cost. Low cost, high production efficiency, high embedding rate of the produced microcapsule preparation, good anti-oxidation performance, slow degradation speed of the finished product, quality controllable microcapsule tyvanectin tartrate preparation and its production process

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Microcapsule type tylosin tartrate preparation and production technology thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0019] The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some, not all, embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.

[0020] The microcapsule tyvalomectin tartrate preparation comprises maltodextrin, sodium caseinate, tyvanectin tartrate bulk drug, purified water and tartaric acid solution. The ratio of the maltodextrin, sodium caseinate, and tyvanectin tartrate bulk drug is 3:1:1.3. The pH of the tartaric acid solution is 4.0-4.1, and the mass of the tartaric acid solution accounts for 50% of the total amount.

[0021] see figure 1 , is a process flow diagram of the produc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a microcapsule type tylosin tartrate preparation and a production technology thereof. The microcapsule type tylosin tartrate preparation is prepared from maltodextrin, sodium caseinate, a crude tylosin tartrate drug, purified water and a tartaric acid solution. The microcapsule type tylosin tartrate preparation and the production technology thereof have the advantages that a preparation method is simple and feasible, the production efficiency is high, the produced microcapsule type preparation is high in encapsulation rate, good in anti-oxidation performance, slow to degrade, controllable in quality and the like.

Description

technical field [0001] The invention belongs to the field of microbial fermentation engineering, and in particular relates to a microcapsule tyvanectin tartrate preparation and a production process thereof. Background technique [0002] Tylosin tartrate has specific effects on mycoplasma and is used as the drug of choice for anti-mycoplasma disease. The existing tylosin tartrate preparation has low production efficiency, and the produced preparation has poor anti-oxidation performance, fast degradation speed of the finished product, and difficult quality control. Contents of the invention [0003] In order to solve the technical problems that the existing tylosin tartrate preparation method is complicated, the production efficiency is low, the anti-oxidation performance of the produced preparation is not good, the degradation speed of the finished product is fast, and the quality is difficult to control, the present invention provides a simple preparation method and low pr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/50A61K47/36A61K47/42A61K31/7048A61P31/04
CPCA61K9/5036A61K9/5052A61K31/7048
Inventor 靳连标李承立钟迎东
Owner 内蒙古中牧生物药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products